IP Library Granted Patent US 8,580,767
Granted Patent B2
US 8,580,767 · App. 12/787,293 · Granted Nov 12, 2013

Oxazolidinone containing dimer compounds, compositions and methods to make and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,767
App. No.
12/787,293
Granted
Nov 12, 2013
Kind
B2
Abstract

Dosage forms or pharmaceutical compositions comprise a compound having the structure of Formula IV: wherein n is a non-negative integer; wherein each Z is an oxazolidinone-containing moiety having antibiotic activity in vivo upon cleaving, wherein M is independently OR 1 or NR 1 R 2 ; wherein R 1 and R 2 are independently selected from the group consisting of H, an optionally-substituted hydrocarbyl residue or a pharmaceutically acceptable cation; wherein the compound in the dosage form or a pharmaceutical composition is present in an amount effective for treating or preventing an antibacterial infection in a mammalian subject. Methods of preparing and using these dosage forms or pharmaceutical compositions are also disclosed.

Claims (24)

1. A pharmaceutical composition comprising a therapeutically effective amount of a compound having the following structure

wherein each Z is

wherein * is the point of attachment of Z to P;

wherein M OR 1 ;

wherein R1 is H or a pharmaceutically acceptable cation.

2. The pharmaceutical composition of claim 1 , wherein the pharmaceutically acceptable cation is a sodium cation.

3. The pharmaceutical composition of claim 1 ,

wherein each Z is

4. The pharmaceutical composition of claim 1 , further comprising a pharmaceutically acceptable carrier, diluent or excipient.

5. The pharmaceutical composition of claim 2 , wherein the structure is:

or the sodium salt thereof.

6. A method of preparing the compound in the pharmaceutical composition of claim 1 , comprising the step of treating a compound of the formula Z—H with a phosphorylating agent.

7. A method of preparing the compound in the pharmaceutical composition of claim 1 , comprising the step of treating with a dehydrating agent the compound Z—P′, wherein P′ is a mono-or dihydrogen phosphate group.

8. The method of claim 6 , wherein the phosphorylating agent is POCl 3 .

9. A method of treating a bacterial infection comprising

administering the pharmaceutical composition of claim 1 to a subject in need thereof.

10. A method of treating a bacterial infection comprising

administering the pharmaceutical composition of claim 2 to a subject in need thereof.

11. A method of treating a bacterial infection comprising

administering the pharmaceutical composition of claim 4 to a subject in need thereof.

12. A method of treating a bacterial infection comprising

administering the pharmaceutical composition of claim 5 to a subject in need thereof.

13. The pharmaceutical composition of claim 2 , further comprising a pharmaceutically acceptable carrier, diluent or excipient.

14. The pharmaceutical composition of claim 5 , further comprising a pharmaceutically acceptable carrier, diluent or excipient.

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 3, 2015
From: TRIUS THERAPEUTICS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036484/0796 →
CHANGE OF NAME Recorded Sep 2, 2015
From: TRIUS THERAPEUTICS, INC.
To: TRIUS THERAPEUTICS LLC
Reel/Frame 036528/0029 →
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: TRIUS THERAPEUTICS, INC.; OPTIMER PHARMACEUTICALS, INC.
Reel/Frame 036178/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2014
From: PHILLIPSON, DOUGLAS
To: TRIUS THERAPEUTICS, INC.
Reel/Frame 033337/0257 →
SECURITY AGREEMENT Recorded Nov 13, 2013
From: OPTIMER PHARMACEUTICALS, INC.; TRIUS THERAPEUTICS INC.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 031628/0850 →